Abstract
Sinonasal teratocarcinosarcoma (SNTCS) is a distinctly rare tumor characterized by a variegated histologic architecture of epithelial and mesenchymal components. By reported accounts, SNTCS is a highly malignant tumor displaying rapid, aggressive growth. Prognosis is poor: less than 45% of all patients survive past 5 years. Combination surgery and radiotherapy currently appear to be the most effective treatment. This report presents a 76-year-old African American man with a SNTCS in the right nasal cavity and paranasal sinuses. The patient was treated with combination surgical excision and postoperative radiation therapy. The clinical and pathologic features and clinical course will be discussed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 29-32 |
| Number of pages | 4 |
| Journal | American Journal of Clinical Oncology: Cancer Clinical Trials |
| Volume | 27 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 1 2004 |
Keywords
- Radiation therapy
- Sinonasal teratocarcinosarcoma
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint Dive into the research topics of 'Sinonasal Teratocarcinosarcoma'. Together they form a unique fingerprint.
Cite this
Chao, K. K., Eng, T. Y., Barnes, J., & Dahiya, R. (2004). Sinonasal Teratocarcinosarcoma. American Journal of Clinical Oncology: Cancer Clinical Trials, 27(1), 29-32. https://doi.org/10.1097/01.coc.0000045851.76922.2E